InvestorsHub Logo
Followers 32
Posts 2803
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 04/23/2020 9:26:11 PM

Thursday, April 23, 2020 9:26:11 PM

Post# of 301
The company's third trial for its anti-BCMA CAR-T therapy is now recruiting https://clinicaltrials.gov/ct2/show/NCT04171843
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DTIL News